Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial
Overview
Authors
Affiliations
The impact of variation in host genetics on replication of human immunodeficiency virus type 1 (HIV-1) in demographically diverse populations remains uncertain. In the current study, we performed a genome-wide screen for associations of single-nucleotide polymorphisms (SNPs) to viral load (VL) in antiretroviral therapy-naive participants (n = 2440) with varying demographics from the Strategic Timing of AntiRetroviral Treatment (START) trial. Associations were assessed using genotypic data generated by a customized SNP array, imputed HLA alleles, and multiple linear regression. Genome-wide significant associations between SNPs and VL were observed in the major histocompatibility complex class I region (MHC I), with effect sizes ranging between 0.14 and 0.39 log10 VL (copies/mL). Supporting the SNP findings, we identified several HLA alleles significantly associated with VL, extending prior observations that the (MHC I) is a major host determinant of HIV-1 control with shared genetic variants across diverse populations and underscoring the limitations of genome-wide association studies as being merely a screening tool.
Morup S, Leung P, Reilly C, Sherman B, Chang W, Milojevic M AIDS Res Ther. 2024; 21(1):27.
PMID: 38698440 PMC: 11067292. DOI: 10.1186/s12981-024-00610-x.
Grohmann C, Shull C, Crum T, Schwab C, Safranski T, Decker J Genet Sel Evol. 2023; 55(1):62.
PMID: 37710159 PMC: 10500877. DOI: 10.1186/s12711-023-00836-9.
Germline immunoglobulin genes: disease susceptibility genes hidden in plain sight?.
Collins A, Yaari G, Shepherd A, Lees W, Watson C Curr Opin Syst Biol. 2023; 24:100-108.
PMID: 37008538 PMC: 10062056. DOI: 10.1016/j.coisb.2020.10.011.
A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors.
Thibord F, Chan M, Chen M, Johnson A HGG Adv. 2022; 3(2):100095.
PMID: 35224516 PMC: 8863308. DOI: 10.1016/j.xhgg.2022.100095.
Current HLA Investigations on SARS-CoV-2 and Perspectives.
Douillard V, Castelli E, Mack S, Hollenbach J, Gourraud P, Vince N Front Genet. 2021; 12:774922.
PMID: 34912378 PMC: 8667766. DOI: 10.3389/fgene.2021.774922.